Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
SYRUP
**RECOMMENDED DOSAGE:** Adults:1 to 2 teaspoonfuls to be taken 3 or 4 times a day.Children:6 to 12 years : 1 teaspoonful 3 times a day. 2 to 6 years : ½ teaspoonful 3 times a day.Note:1 teaspoonful is equal to 5 ml.
ORAL
Medical Information
**INDICATIONS:** For productive cough; symptomatic relief of sneezing and rhinorrhoea.
**CONTRAINDICATIONS:** Ammonium salts are contraindicated in the presence of impaired hepatic or renal function. Patients with narrow angle glaucoma; prostatic hypertrophy. Diphenhydramine may exacerbate porphyria.
R05FB01
cough suppressants and mucolytics
Manufacturer Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
PT ACTAVIS INDONESIA
Active Ingredients
Documents
Package Inserts
Att 8 AAAM6807 Phenexpect Syp PI Prop Ann.pdf
Approved: January 19, 2021